McNeil Recalls 200,000 bottles of Concentrated MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. ("McNeil") is voluntarily recalling at the retail level three lots, approximately 200,000 bottles, of Concentrated MOTRIN® Infants' Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States (see full product list below).  This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).  McNeil is asking retailers to remove the affected lots from store shelves and is asking consumers to stop using and dispose of any product they may have that is included in this recall.

After releasing these three lots of Concentrated MOTRIN® Infants' Drops Original Berry Flavor 1/2 fl oz into the market, tiny plastic particles (approximately 1 mm in size or about the size of a poppy seed) were identified in a different product lot during manufacturing.  This lot was not released to the market.  It was determined that the particles originated in a shipment from a third party supplier of ibuprofen, the active ingredient in Concentrated MOTRIN® Infants' Drops Original Berry Flavor 1/2 fl oz.  Out of an abundance of caution, McNeil is voluntarily recalling the three lots released to the market made with the same batch of active ingredient.  McNeil has worked with the third party to ensure that corrective measures are currently in place and are effective.  The potential for adverse medical events related to the reason for this recall is not likely.  Concentrated Infants' MOTRIN® Drops Dye-Free Berry Flavor 1 fl oz is not included in this recall.  Children's or Adult MOTRIN® products are not included in this recall.

If you have any questions or concerns, or would like to inquire about a refund, please call our Consumer Care Center at 1-877-414-7709.  Parents and caregivers with any health questions or concerns should contact their healthcare provider and visit www.motrin.com for additional information.

FULL RECALLED PRODUCT LIST:

Adverse events that may be related to the use of this product may be reported to U.S. Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

SOURCE McNeil Consumer Healthcare

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experts call for coordinated global action to make the most of Alzheimer’s treatments